Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

84 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AstraZeneca : 2023 Sustainability Highlights presentation
PU
Transcript : AstraZeneca PLC - Special Call
AstraZeneca to boost cell therapy operations with $300m manufacturing investment
AQ
AstraZeneca expands US manufacturing footprint to accelerate ambitions in next-generation cell therapy discovery and development
BU
Smiths Group plc Announces Directors' Change in Responsibilities
CI
AstraZeneca to leverage its global industrial-scale manufacturing and digital capabilities to boost US renewable natural gas productivity
BU
LTC Properties : Supplemental Operating & Financial Data
PU
Smiths : 2023 Notice of Annual General Meeting
PU
AstraZeneca announces innovative partnership with Vanguard Renewables to decarbonize its United States sites
BU
AstraZeneca : 2022 Sustainability Highlights presentation
PU
LTC Properties : Q4 2022 Supplemental Operating and Financial Data
PU
Smiths : 2022 Annual General Meeting Voting Results
PU
Smiths : Notice of AGM
PU
Transcript : AstraZeneca PLC, Q1 2022 Earnings Call, Apr 29, 2022
Model N Completes Rainmaker22: Largest Virtual Conference Reporting on the Outlook for Revenue Optimization and Compliance
BU
LTC Properties : Q4 2021 Supplemental Operating and Financial Data-Amended
PU
LTC Properties : Q4 2021 Supplemental Operating and Financial Data
PU
Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy
PR
Smiths : 2021 Annual General Meeting Voting Results
PU
Smiths : 2021 Notice of Annual General Meeting
PU
Q3 2021 Supplemental Operating and Financial Data
PU
AstraZeneca : Investment will transform development and commercialisation of new medicines (Form 6-K)
PU
AstraZeneca to invest $360 million in Irish drug manufacturing site
RE
AstraZeneca : to invest $360m in advanced manufacturing facility in Ireland
PU
LTC Properties : Q2 2021 Supplemental Operating and Financial Data
PU
Transcript : LTC Properties, Inc. - Shareholder/Analyst Call
Imperva® to Acquire CloudVector, Accelerates Vision for Web Application and API Protection
BU
Transcript : LTC Properties, Inc., Q1 2021 Earnings Call, Apr 30, 2021
Transcript : AstraZeneca PLC, Q1 2021 Earnings Call, Apr 30, 2021
LTC Properties : Transcript of LTC Properties, Inc. Q1 2021 Earnings Call
PU
Mountain Commerce Bancorp : Bank Announces Promotions for Ten Key TriCities Team Members
PU
AstraZeneca : Vaccine production not perfect but our drug saves lives, AstraZeneca says, as Africa backs COVID-19 shot
RE
Vaccine production not perfect but our drug saves lives, AstraZeneca says, as Africa backs COVID-19 shot
RE
Transcript : AstraZeneca PLC, Q4 2020 Earnings Call, Feb 11, 2021
AstraZeneca : Gears Up to Vaccinate the World Against Covid-19
DJ
AstraZeneca : Encouraging Oxford vaccine results keep Britain on track for spring roll-out
RE
Instant View: AstraZeneca says its coronavirus vaccine can be around 90% effective
RE
Instant view: AstraZeneca says its coronavirus vaccine can be around 90% effective
RE
AstraZeneca will have enough COVID-19 vaccine for 200 million doses this year
RE
Smiths : 2020 Annual General Meeting Presentation
PU
Smiths : 2020 Annual General Meeting Voting Results
PU
Transcript : AstraZeneca PLC, Q3 2020 Earnings Call, Nov 05, 2020
Medtronic : Biennial 2020 Investor & Analyst Meeting - Citations
PU
Samsung Biologics : and AstraZeneca forge strategic manufacturing partnership for global supply
PR
Transcript : AstraZeneca PLC, H1 2020 Earnings Call, Jul 30, 2020
Merck : FDA Approves Merck's KEYTRUDA for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma that is Not Curable by Surgery or Radiation
AQ
Transcript : AstraZeneca PLC, Q1 2020 Earnings Call, Apr 29, 2020
Transcript : Smiths Group plc - Shareholder/Analyst Call
Arbutus Reports Third Quarter 2019 Financial Results and Provides Corporate Update
GL
DesignCon Presents 2020 Conference Programming Exploring the Evolving Electronics Design Landscape for its 25th Edition
GL
No results for this search
  1. Stock Market
  2. Advanced search
  3. Pam Cheng
  4. News